Tango Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.05B-0.06B-0.11B-0.10B-0.13B
Depreciation and Depletion 0.00B0.00B0.00B0.00B0.00B
Share-based Compensation 0.00B0.01B0.01B0.02B0.03B
Gains from Sales and Divestitures 0.00B0.00B0.00B0.00B
Gains from Investment Securities 0.00B0.01B0.01B0.02B0.02B
Non-cash Items 6.64B51.42B0.00B0.01B0.01B
Cash from Operations 0.07B-0.06B-0.11B-0.12B-0.13B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00B0.00B0.00B0.00B-0.00B
Depreciation & Amortization (CF) 0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables 0.00B-0.00B
Change in Account Payables 0.00B0.00B0.00B-0.00B-0.00B
Change in Accured Expenses 0.00B0.00B0.01B-0.00B0.00B
Other Working Capital Changes 0.12B-0.01B-0.02B-0.03B-0.03B
Investing Activities
Capital Expenditures 0.00B0.00B0.01B0.00B0.00B
Change in Acquisitions & Divestments 0.06B0.19B0.24B0.35B0.33B
Cash from Investing Activities -0.15B-0.18B0.03B0.04B0.09B
Financing Activities
Other financing activities 0.00B0.00B
Cash from Financing Activities 0.08B0.36B0.00B0.08B0.05B
Additional items
Change in Cash 0.01B0.11B-0.08B0.01B0.00B
Free Cash Flow 0.07B-0.06B-0.12B-0.12B-0.13B
Net Cash Flow 0.01B0.11B-0.08B0.01B0.00B